Literature DB >> 15616922

Can laparoscopic antireflux surgery improve the quality of life in children with neurologic and neuromuscular handicaps?

Hisayoshi Kawahara1, Hiroomi Okuyama, Akio Kubota, Takaharu Oue, Yuko Tazuke, Makoto Yagi, Akira Okada.   

Abstract

PURPOSE: Children with neurologic and neuromuscular handicaps frequently have various symptoms related to gastroesophageal reflux (GER) disease. The long-term efficacy of antireflux surgery remains controversial in such children with GER. The clinical results of such patients who underwent laparoscopic fundoplication were examined in the current study.
METHODS: Between 1997 and 2003, laparoscopic fundoplication was performed in 56 handicapped children (mean age, 6 years), and gastrostomy was performed concurrently in 52. The main symptoms were emesis/hematemesis in 40 and respiratory symptoms, including repeated respiratory infection and distress, in 31.
RESULTS: There were no severe postoperative complications or operative mortality. Emesis/hematemesis was controlled adequately in those without recurrence. Respiratory symptoms were controlled unsuccessfully in 16 patients (52%), 8 of whom required further respiratory care including nasal airway tube, tracheostomy, and laryngotracheal separation. Recurrence of GER disease occurred in 10 patients, 7 of whom underwent a second Nissen fundoplication successfully. Thirteen died within the median follow-up period of 14 months.
CONCLUSIONS: Laparoscopic fundoplication is effective in controlling emesis/hematemesis, but its efficacy is limited in terms of respiratory problems in handicapped children. Further refinements in diagnostic and treatment strategies are mandatory to improve the quality of life in such patients.

Entities:  

Mesh:

Year:  2004        PMID: 15616922     DOI: 10.1016/j.jpedsurg.2004.08.034

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  8 in total

Review 1.  Outcomes of fundoplication: causes for concern, newer options.

Authors:  E Hassall
Journal:  Arch Dis Child       Date:  2005-10       Impact factor: 3.791

Review 2.  Laparoscopic fundoplication for gastroesophageal reflux disease in infants and children.

Authors:  Tadashi Iwanaka; Yutaka Kanamori; Masahiko Sugiyama; Makoto Komura; Yujiro Tanaka; Tetsuro Kodaka; Tetsuya Ishimaru
Journal:  Surg Today       Date:  2010-04-28       Impact factor: 2.549

Review 3.  Outcomes of pediatric laparoscopic fundoplication: a critical review of the literature.

Authors:  Kathryn Martin; Catherine Deshaies; Sherif Emil
Journal:  Can J Gastroenterol Hepatol       Date:  2013-11-28

4.  Impact of laparoscopic anterior 270 degrees fundoplication on the quality of life and symptoms profile of neurodevelopmentally delayed versus neurologically unimpaired children and their parents.

Authors:  Carsten Engelmann; Stella Gritsa; Benno Manfred Ure
Journal:  Surg Endosc       Date:  2009-12-24       Impact factor: 4.584

5.  Mesh hiatal reinforcement in laparoscopic Nissen fundoplication for neurologically impaired children is safe and feasible.

Authors:  Hizuru Amano; Yujiro Tanaka; Hiroshi Kawashima; Kyoichi Deie; Keisuke Suzuki; Michimasa Fujiogi; Kaori Morita; Tadashi Iwanaka; Hiroo Uchida
Journal:  Nagoya J Med Sci       Date:  2017-11       Impact factor: 1.131

6.  Laparoscopic antireflux surgery increases health-related quality of life in children with GERD.

Authors:  Femke A Mauritz; Rebecca K Stellato; L W Ernst van Heurn; Peter D Siersema; Cornelius E J Sloots; Roderick H J Houwen; David C van der Zee; Maud Y A van Herwaarden-Lindeboom
Journal:  Surg Endosc       Date:  2016-11-18       Impact factor: 4.584

7.  Surgical management of pediatric gastroesophageal reflux disease.

Authors:  Hope T Jackson; Timothy D Kane
Journal:  Gastroenterol Res Pract       Date:  2013-05-09       Impact factor: 2.260

8.  Effects and efficacy of laparoscopic fundoplication in children with GERD: a prospective, multicenter study.

Authors:  Femke A Mauritz; J M Conchillo; L W E van Heurn; P D Siersema; C E J Sloots; R H J Houwen; D C van der Zee; M Y A van Herwaarden-Lindeboom
Journal:  Surg Endosc       Date:  2016-07-01       Impact factor: 4.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.